Regulus Therapeutics Inc.

NASDAQ (USD): Regulus Therapeutics Inc. (RGLS)

Last Price

1.59

Today's Change

+0.04 (2.58%)

Day's Change

1.51 - 1.60

Trading Volume

424,474

Overview

Market Cap

104 Million

Shares Outstanding

65 Million

Avg Volume

337,704

Avg Price (50 Days)

1.52

Avg Price (200 Days)

1.89

PE Ratio

-1.56

EPS

-1.02

Earnings Announcement

19-Mar-2025

Previous Close

1.55

Open

1.53

Day's Range

1.5101 - 1.6

Year Range

1.08 - 3.79

Trading Volume

413,882

Price Change Highlight

1 Day Change

2.58%

5 Day Change

1.27%

1 Month Change

13.57%

3 Month Change

-12.64%

6 Month Change

-36.65%

Ytd Change

21.37%

1 Year Change

28.23%

3 Year Change

-55.83%

5 Year Change

-75.91%

10 Year Change

-99.92%

Max Change

-99.68%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Discussions
Be the first to like this. Showing 1 of 1 comments

actvtrader

I like the 50.00 price target for yahoo!

2014-10-22 15:48

Post a Comment